Computer technology to help FDA test drug efficacy

12/16/2008 | Wall Street Journal, The

The FDA reached a deal to use Entelos' simulation technology to test the effects of three medicines being developed for cardiovascular ailments. Entelos said its Cardiovascular PhysioLab mathematically interprets chemical properties of drugs to predict whether they will cause heart problems and to identify at-risk individuals. The project aims "to anticipate bad scenarios before they occur," an FDA official said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC